XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
TOTAL REVENUE $ 47,638 $ 38,350 $ 62,898
COST OF GOODS SOLD (19,592) (16,349) (10,873)
RESEARCH AND DEVELOPMENT EXPENSES (29,349) (29,734) (38,167)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (11,711) (12,729) (11,148)
OPERATING INCOME (LOSS) (13,014) (20,462) 2,710
FINANCIAL EXPENSES (2,529) (7,521) (9,671)
FINANCIAL INCOME 1,146 401 438
FINANCIAL EXPENSES, NET (1,383) (7,120) (9,233)
LOSS BEFORE TAXES ON INCOME (14,397) (27,582) (6,523)
TAXES ON INCOME (530)    
NET LOSS FOR THE YEAR $ (14,927) $ (27,582) $ (6,523)
LOSS PER SHARE OF COMMON STOCK - BASIC $ (0.31) $ (0.62) $ (0.22)
LOSS PER SHARE OF COMMON STOCK - DILUTED $ (0.31) $ (0.62) $ (0.22)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC 48,472,159 44,140,233 29,148,047
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED 48,472,159 44,140,233 29,148,047
Goods      
TOTAL REVENUE $ 25,292 $ 16,749 $ 16,236
License and R&D Services      
TOTAL REVENUE $ 22,346 $ 21,601 $ 46,662